Citation Impact

Citing Papers

Genome-wide study of methotrexate clearance replicates SLCO1B1
2012
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
2020
Nickel‐Catalyzed Decarboxylative Acylation of Heteroarenes by sp2 CH Functionalization
2014
3‐Substituted 2‐Phenylimidazo[2,1‐b]benzothiazoles: Synthesis, Anticancer Activity, and Inhibition of Tubulin Polymerization
2012
PROTAC targeted protein degraders: the past is prologue
2022 Standout
The ChEMBL database in 2017
2016 Standout
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation
2021
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
2011
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
3d Transition Metals for C–H Activation
2018 Standout
Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects
2021
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
2015 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry
2013
Stereoselective Copper-Catalyzed Cross-Coupling of Aziridines with Benzimidazoles via Nucleophilic Ring Opening and C(sp2)–H Functionalization
2017
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Metal-Catalyzed Decarboxylative C–H Functionalization
2017 Standout
Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action
2016
Sesquiterpene Lactones and Their Derivatives Inhibit High Glucose-Induced NF-κB Activation and MCP-1 and TGF-β1 Expression in Rat Mesangial Cells
2013
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Flavonoids in Cancer and Apoptosis
2018 Standout
Graphene family, and their hybrid structures for electromagnetic interference shielding applications: Recent trends and prospects
2021 Standout
Current strategies for the design of PROTAC linkers: a critical review
2020
Chemistry: Chemical con artists foil drug discovery
2014 StandoutNature
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer
2021
ZINC 15 – Ligand Discovery for Everyone
2015 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout

Works of Sunjoo Ahn being referenced

Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition
2010
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
2020
Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization
2011
αVβ3-Targeted Delivery of Camptothecin-Encapsulated Carbon Nanotube-Cyclic RGD in 2D and 3D Cancer Cell Culture
2019
Inhibitors of Tubulin Assembly Identified through Screening a Compound Library
2008
Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera
2019
Competitive mass spectrometry binding assay for characterization of three binding sites of tubulin
2010
Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
2014
Discovery of Novel 2-Aryl-4-benzoyl-imidazole (ABI-III) Analogues Targeting Tubulin Polymerization As Antiproliferative Agents
2012
Rankless by CCL
2026